Literature DB >> 26709246

Should This Patient With Ischemic Stroke Receive Fluoxetine?

Heidi Schambra1, Brian Im2, Michael W O'Dell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26709246      PMCID： PMC4743253          DOI： 10.1016/j.pmrj.2015.11.007

Source DB:  PubMed          Journal:  PM R        ISSN： 1934-1482            Impact factor:   2.298


× No keyword cloud information.
  17 in total

Review 1.  Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.

Authors:  An Pan; Qi Sun; Olivia I Okereke; Kathryn M Rexrode; Frank B Hu
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study.

Authors:  M Kotila; H Numminen; O Waltimo; M Kaste
Journal:  Eur J Neurol       Date:  1999-05       Impact factor: 6.089

3.  The responsiveness of the Action Research Arm test and the Fugl-Meyer Assessment scale in chronic stroke patients.

Authors:  J H van der Lee; H Beckerman; G J Lankhorst; L M Bouter
Journal:  J Rehabil Med       Date:  2001-03       Impact factor: 2.912

4.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

Authors:  François Chollet; Jean Tardy; Jean-François Albucher; Claire Thalamas; Emilie Berard; Catherine Lamy; Yannick Bejot; Sandrine Deltour; Assia Jaillard; Philippe Niclot; Benoit Guillon; Thierry Moulin; Philippe Marque; Jérémie Pariente; Catherine Arnaud; Isabelle Loubinoux
Journal:  Lancet Neurol       Date:  2011-01-07       Impact factor: 44.182

5.  Depression after minor stroke: prevalence and predictors.

Authors:  M Altieri; I Maestrini; A Mercurio; P Troisi; E Sgarlata; V Rea; V Di Piero; G L Lenzi
Journal:  Eur J Neurol       Date:  2011-12-19       Impact factor: 6.089

6.  Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS).

Authors:  Jonathan W Sturm; Geoffrey A Donnan; Helen M Dewey; Richard A L Macdonell; Amanda K Gilligan; Velandai Srikanth; Amanda G Thrift
Journal:  Stroke       Date:  2004-08-26       Impact factor: 7.914

Review 7.  Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis.

Authors:  Daniel G Hackam; Marko Mrkobrada
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

8.  National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.

Authors:  Dawn Kleindorfer; Christopher J Lindsell; Lawrence Brass; Walter Koroshetz; Joseph P Broderick
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

9.  Inter-individual variability in the capacity for motor recovery after ischemic stroke.

Authors:  Shyam Prabhakaran; Eric Zarahn; Claire Riley; Allison Speizer; Ji Y Chong; Ronald M Lazar; Randolph S Marshall; John W Krakauer
Journal:  Neurorehabil Neural Repair       Date:  2007-08-08       Impact factor: 3.919

10.  Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study.

Authors:  Huai Wu Yuan; Chun Xue Wang; Ning Zhang; Ying Bai; Yu Zhi Shi; Yong Zhou; Yi Long Wang; Tong Zhang; Juan Zhou; Xin Yu; Xin Yu Sun; Zhao Rui Liu; Xing Quan Zhao; Yong Jun Wang
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240
View more
  1 in total

1.  Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.

Authors: 
Journal:  Lancet       Date:  2018-12-05       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.